Paris-based medtech startup Artedrone is advancing a groundbreaking microrobotic system designed to autonomously navigate the brain’s vasculature and remove blood clots, offering a new approach to stroke care with the potential to dramatically expand access beyond specialized treatment centers. Known as the Sasha system, the technology combines robotic catheterization, magnetic guidance, advanced imaging, and artificial intelligence to perform mechanical thrombectomy procedures with minimal operator intervention. Currently in preclinical development, Artedrone has submitted initial findings for publication and is targeting a first-in-human trial by 2027.
The Sasha system operates by using CT or MRI imaging to create a digital twin of the patient’s brain vasculature. This model is used to pre-map a path to the clot. During the procedure, an interventionalist accesses the patient’s arterial system through the groin and guides the catheter up to the carotid artery. From that point—referred to as the “base camp”—the microrobot takes over, propelled passively by blood flow. As it encounters bifurcations in the vessels, magnetic fields from an external device are used to steer the catheter by pulling or pushing a magnetic component on the device in the desired direction. This step-by-step advancement continues until the device reaches the target site.
Continue reading… “Artedrone Develops Autonomous Robotic System to Expand Access to Stroke Treatment”
